ZA857B - Inert matrix based on polycaprolactone for the oral administration of a drug,and method for the preparation of the galenic form comprising this matrix - Google Patents

Inert matrix based on polycaprolactone for the oral administration of a drug,and method for the preparation of the galenic form comprising this matrix

Info

Publication number
ZA857B
ZA857B ZA857A ZA857A ZA857B ZA 857 B ZA857 B ZA 857B ZA 857 A ZA857 A ZA 857A ZA 857 A ZA857 A ZA 857A ZA 857 B ZA857 B ZA 857B
Authority
ZA
South Africa
Prior art keywords
matrix
preparation
polycaprolactone
drug
oral administration
Prior art date
Application number
ZA857A
Other languages
English (en)
Inventor
Herve Grouiller
Fabien Christ
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of ZA857B publication Critical patent/ZA857B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
ZA857A 1984-01-02 1985-01-02 Inert matrix based on polycaprolactone for the oral administration of a drug,and method for the preparation of the galenic form comprising this matrix ZA857B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8400015A FR2557459B1 (fr) 1984-01-02 1984-01-02 Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice

Publications (1)

Publication Number Publication Date
ZA857B true ZA857B (en) 1985-08-28

Family

ID=9299789

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA857A ZA857B (en) 1984-01-02 1985-01-02 Inert matrix based on polycaprolactone for the oral administration of a drug,and method for the preparation of the galenic form comprising this matrix

Country Status (23)

Country Link
US (1) US4629624A (fr)
EP (1) EP0147335B1 (fr)
JP (1) JPS60185729A (fr)
KR (1) KR850005271A (fr)
AT (1) ATE33553T1 (fr)
AU (1) AU574024B2 (fr)
CA (1) CA1238856A (fr)
CS (1) CS247190B2 (fr)
DD (1) DD235829A5 (fr)
DE (1) DE3470459D1 (fr)
DK (1) DK616084A (fr)
ES (1) ES8605682A1 (fr)
FI (1) FI79942C (fr)
FR (1) FR2557459B1 (fr)
GR (1) GR82607B (fr)
HU (1) HU193731B (fr)
IL (1) IL73957A (fr)
NO (1) NO160412C (fr)
OA (1) OA08018A (fr)
PH (1) PH22167A (fr)
PT (1) PT79786B (fr)
YU (1) YU223884A (fr)
ZA (1) ZA857B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
DE3701625A1 (de) * 1987-01-21 1988-08-04 Boehringer Ingelheim Kg Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
GB8805286D0 (en) * 1988-03-05 1988-04-07 Schering Agrochemicals Ltd Trypanocides
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
CA2540984C (fr) * 2003-10-10 2011-02-08 Lifecycle Pharma A/S Forme de dose solide comprenant un fibrate
BRPI0415121A (pt) * 2003-10-10 2006-11-28 Lifecycle Pharma As material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
FR2912752B1 (fr) * 2007-02-16 2012-10-05 Arkema France Procede de preparation d'un copolymere d'au moins un monomere cyclique
FR2912751B1 (fr) * 2007-02-16 2012-07-13 Arkema France Procede de preparation de polylactones et polylactames
AU2013203747B2 (en) * 2008-09-18 2016-01-07 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(e-caprolactone)
NZ592276A (en) * 2008-09-18 2012-12-21 Purdue Pharma Lp PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(epsilon-CAPROLACTONE) AND AN OPIOID
ES2603278T3 (es) * 2011-12-09 2017-02-24 Purdue Pharma Lp Formas farmacéuticas de dosificación que comprenden poli (epsilon-caprolactona) y óxido de polietileno

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1490855A (fr) * 1965-08-27 1967-08-04 Shell Int Research Procédé pour la fabrication d'articles en polyesters provenant de la polymérisation des lactones
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3929937A (en) * 1972-07-28 1975-12-30 Union Carbide Corp Biodegradable shaped articles from a material comprising a particulate addition polymer in a matrix of a thermoplastic oxyalkanoyl polymer
US4095791A (en) * 1976-08-23 1978-06-20 Fairchild Camera And Instrument Corp. Cartridge programmable video game apparatus
FR2377431A1 (fr) * 1977-01-12 1978-08-11 Inst Sint Smol Procede de preparation de materiaux polymeres a pores ouverts
FR2397840B1 (fr) * 1977-07-22 1981-03-20 Cherqui Jean
US4148871A (en) * 1977-10-11 1979-04-10 Pitt Colin G Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers

Also Published As

Publication number Publication date
FI79942C (fi) 1990-04-10
PH22167A (en) 1988-06-28
CA1238856A (fr) 1988-07-05
IL73957A0 (en) 1985-03-31
FI79942B (fi) 1989-12-29
AU574024B2 (en) 1988-06-23
FI845088L (fi) 1985-07-03
NO160412C (no) 1989-04-19
DE3470459D1 (en) 1988-05-26
US4629624A (en) 1986-12-16
FR2557459A1 (fr) 1985-07-05
NO160412B (no) 1989-01-09
FI845088A0 (fi) 1984-12-21
NO845273L (no) 1985-07-03
KR850005271A (ko) 1985-08-24
ATE33553T1 (de) 1988-05-15
YU223884A (en) 1987-10-31
JPS60185729A (ja) 1985-09-21
FR2557459B1 (fr) 1986-05-30
AU3720984A (en) 1985-07-11
HU193731B (en) 1987-11-30
ES8605682A1 (es) 1986-04-01
GR82607B (en) 1985-02-11
DK616084A (da) 1985-07-03
DD235829A5 (de) 1986-05-21
ES539187A0 (es) 1986-04-01
DK616084D0 (da) 1984-12-20
EP0147335A3 (en) 1985-07-31
CS247190B2 (en) 1986-12-18
PT79786A (fr) 1985-02-01
EP0147335B1 (fr) 1988-04-20
HUT37567A (en) 1986-01-23
IL73957A (en) 1988-02-29
OA08018A (fr) 1987-01-31
PT79786B (fr) 1986-10-28
EP0147335A2 (fr) 1985-07-03

Similar Documents

Publication Publication Date Title
ZA857B (en) Inert matrix based on polycaprolactone for the oral administration of a drug,and method for the preparation of the galenic form comprising this matrix
HUT49366A (en) Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same
CA2021767A1 (fr) Methode de preparation d'un compose pharmaceutique sous forme de microparticules
EP0248594A3 (en) Pharmacologically active 1,5-diaryl-3-substituted-pyrazopharmacologically active 1,5-diaryl-3-substituted-pyrazoles and method for synthesizing the same les and method for synthesizing the same
JPS6426578A (en) 2,2-dimethylchroman-3-ol derivative, manufacture and drug composition
NZ224189A (en) 6-substituted 2',3'-dideoxynucleosides and pharmaceutical compositions
EP1302207A3 (fr) Procede pour la preparation d'un agent antihypertensif contenant un dipeptide en tant que principe actif
CA2017851A1 (fr) Particules biodegradables micronisees; methode de preparation et utilisation
HUT50844A (en) Process for producing new 2'-halogen methylidene, 2'-ethenylidene and 2'-ethinyladenosine derivatives and pharmaceutical compositions comprising same as active ingredient
HUT54358A (en) Process for producing substituted 1,3,5-triazinetrione derivatives and medical compositions comprising such compounds as active ingredient
NZ223865A (en) 3'-azido or fluoro-2',3'-dideoxyribofuranosyl derivatives and pharmaceutical compositions therefrom
KR960016541B1 (en) 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi2 derivatives, process for their preparation and use thereof
HUT63151A (en) Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient
ZA876182B (en) 2.3-dihydrofuran derivatives,process for preparing them,and their use as an intermediate for the preparation of tetrahydrofuran derivatives
HUT50340A (en) Process for producing 2'-, 12'- or 13'-substituted 3-(8'alpha-ergolinyl)-1,1-diethylurea and pharmaceutical compositions comprising the compounds
HUT49870A (en) Process for producing new 1,2-dithiolo-3-thion-s-oxide derivatives and pharmaceutical compositions comprising these compounds
EP0348664A3 (fr) Compositions pharmaceutiques contenant des monoacétoacétines pour le traitement des tumeurs
EP0301239A3 (en) Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders
PL277260A1 (en) Method of obtaining novel derivatives of tetrahydropyridine
Plotnikov Laws Governing Emission of Sound During Martensite Transformations in TiNi-Base Alloys
Greer Effects of NaCl on tobacco callus cultures
IL85920A0 (en) Substituted 1.3-dioxolane and 1,3-dioxane derivatives,their preparation and pharmaceutical compositions containing them
NZ230418A (en) Substituted 4-azatricyclo (22.3.1.0 4,9 ) octacos-18-ene derivatives, preparation from streptomyces culture, and pharmaceutical compositions
IL86785A0 (en) 1,3-dioxane and tetrahydropyran derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same